No description available.

No description available.

Thesis (PhD)--University of South Australia, 2004.

Thesis (PhD)--University of South Australia, 2003.

Clinical Psychology around the world has evolved dramatically over the last century. This evolution has led to the legislation of psychologists in some States of the United States of America to legally prescribe psychotropic medications. Since 1981 when the first published survey was conducted to assess the views of psychologists towards prescription privileges, advocates and opponents have loudly voiced their opinions. Some of the topics of debate include training, social, professional, economic and political issues. Comparatively, there has been little discussion of limited prescription privileges for clinical psychologists in Australia. The current exploratory study seeks to be the first study in the literature to address the views of South Australian psychologists-in-training and clinical psychologists' views towards limited prescription privileges for clinical psychologists. / An initial sample of 121 respondents were involved in the first stage of the study, whereby respondents clearly perceived more costs than benefits to the profession and the community, should psychologists attain the right to prescribe. A difference in support of prescription privileges was not found between psychologists-in-training, academic or practising psychologists. In addition, gender had no effect on the opinions of respondents. Of those 121 initial respondents, 51 returned the second questionnaire after reading an informal discussion document on the debate. Results indicated that the provision of information produced a significant, favourable change in opinion towards prescription privileges. / The current study reveals a lack of consensus in opinion and the prioritizing of other marketplace issues such as the desire for the profession to attain Medicare rebates as well as a desire for the profession to attain Medicare rebates as well as a desire for additional psychopharmacology training. / Thesis (PhD)--University of South Australia, 2004.

Thesis (MNursing (Advanced Practice))--University of South Australia, 1996

Thesis (MSocSc)--University of South Australia, 1997

Amendements: leaves 252-254. / Copies of author's previously published articles inserted. / Bibliography: leaves 226-251. / vi, 254 leaves : ill. ; 30 cm. / Title page, contents and abstract only. The complete thesis in print form is available from the University Library. / The CYP2C19 and CYP2D6 genetic polymorphisms control the oxidative metabolism of many different drug classes. Populations are separated into groups of extensive metabolisers (EM), poor metabolisers (PM), and in the case of CYP2D6, ultra-rapid metabolisers (UM). In vitro studies using human liver microsomes were conducted to examine the kinetics of the oxidative metabolism of flunitrazepam, and which CYP450 enzymes mediate the oxidative metabolism of flunitrazepam, (S)-mephenytoin and proguanil. / Thesis (Ph.D.)--University of Adelaide, Dept. of Clinical and Experimental Pharmacology, 2000

Addenda and corrigenda inserted on verso of back end paper. / Includes: Publications and communications to learned societies (p. 4-5). / Bibliography: leaves 272-286. / 286 leaves : ill. ; 30 cm. / Title page, contents and abstract only. The complete thesis in print form is available from the University Library. / Examines the acute myocardial uptake of drugs, particularly perindoprilat and enalaprilat in humans. The uptake of these agents is examined, together with the haemodynamic, metabolic and biochemical effects. In particular, the impact of these agents on angiotensin and bradykinin peptides both within the heart and peripherally is described. The acute effects of a range of cardioactive drugs upon the left ventricular force-interval relationship is examined. / Thesis (Ph.D.)--University of Adelaide, Dept. of Medicine, 1999

Thesis (MNursing (Advanced Practice))--University of South Australia, 1996